Last edition
News about "long COVID "
FDA Clears Expanded Access Programme for StemCyte's RegeneCyte Therapy in Long covid Patients
The FDA has approved an Expanded Access programme for StemCyte’s RegeneCyte, enabling eligible Long covid patients to access the cord blood-based therapy amid ongoing clinical trials.
Long Covid | 27/01/2026 | By News Bureau | 107
Virax Biolabs Closes USD 5 Million Private Placement
Virax Biolabs has closed a USD 5 million private placement, extending its cash runway into the first half of 2028 and supporting ongoing regulatory studies for its ViraxImmune platform, including long COVID and post-acute infection syndrome programmes, alongside planned FDA and MHRA submissions and platform expansion initiatives.
Long COVID | 06/12/2025 | By Dineshwori | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy